Literature DB >> 1936958

Repeated use of GAL1 for gene disruption in Candida albicans.

J A Gorman1, W Chan, J W Gorman.   

Abstract

A technique which has the potential to allow repeated use of the same selectable marker to create gene disruptions in Candida albicans has been developed. In this approach, originally described for Saccharomyces cerevisiae, the selectable marker is flanked by direct repeats. Mitotic recombination between these repeats leads to elimination of the selectable marker. A module in which the GALq1 gene is flanked by direct repeats of the bacterial CAT gene was constructed and used to disrupt one copy of the URA3 gene in a gal1 mutant. Gal- revertants were selected by plating on 2-deoxy-D-galactose (2DOG). The frequency of 2DOG-resistant colonies recovered was 20 times higher than that obtained with a similar construct not flanked by direct repeats. Of these, 20% had lost the GAL1 gene by recombination between the direct repeats. The GAL1 gene was used again to disrupt the remaining wild-type copy of the URA3 gene of one of these gal1 isolates, resulting in a stable ura3 mutant. This technique should be generally applicable to derive homozygous gene disruptions in this diploid organism.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1936958      PMCID: PMC1204565     

Source DB:  PubMed          Journal:  Genetics        ISSN: 0016-6731            Impact factor:   4.562


  16 in total

1.  Directed mutagenesis in Candida albicans: one-step gene disruption to isolate ura3 mutants.

Authors:  R Kelly; S M Miller; M B Kurtz; D R Kirsch
Journal:  Mol Cell Biol       Date:  1987-01       Impact factor: 4.272

2.  Assignment of cloned genes to the seven electrophoretically separated Candida albicans chromosomes.

Authors:  B B Magee; Y Koltin; J A Gorman; P T Magee
Journal:  Mol Cell Biol       Date:  1988-11       Impact factor: 4.272

3.  One-step gene disruption in yeast.

Authors:  R J Rothstein
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

4.  Isolation of hem3 mutants from Candida albicans by sequential gene disruption.

Authors:  M B Kurtz; J Marrinan
Journal:  Mol Gen Genet       Date:  1989-05

5.  Targeted transformation of Ascobolus immersus and de novo methylation of the resulting duplicated DNA sequences.

Authors:  C Goyon; G Faugeron
Journal:  Mol Cell Biol       Date:  1989-07       Impact factor: 4.272

6.  Integrative transformation of Candida albicans, using a cloned Candida ADE2 gene.

Authors:  M B Kurtz; M W Cortelyou; D R Kirsch
Journal:  Mol Cell Biol       Date:  1986-01       Impact factor: 4.272

Review 7.  Premeiotic instability of repeated sequences in Neurospora crassa.

Authors:  E U Selker
Journal:  Annu Rev Genet       Date:  1990       Impact factor: 16.830

8.  A Candida albicans dispersed, repeated gene family and its epidemiologic applications.

Authors:  S Scherer; D A Stevens
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

9.  Activation of human immunodeficiency virus type 1 by DNA damage in human cells.

Authors:  K Valerie; A Delers; C Bruck; C Thiriart; H Rosenberg; C Debouck; M Rosenberg
Journal:  Nature       Date:  1988-05-05       Impact factor: 49.962

10.  Isolation of the Candida albicans gene for orotidine-5'-phosphate decarboxylase by complementation of S. cerevisiae ura3 and E. coli pyrF mutations.

Authors:  A M Gillum; E Y Tsay; D R Kirsch
Journal:  Mol Gen Genet       Date:  1984
View more
  20 in total

Review 1.  Molecular genetic and genomic approaches to the study of medically important fungi.

Authors:  P T Magee; Cheryl Gale; Judith Berman; Dana Davis
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

2.  Molecular mechanism of flucytosine resistance in Candida lusitaniae: contribution of the FCY2, FCY1, and FUR1 genes to 5-fluorouracil and fluconazole cross-resistance.

Authors:  Nicolas Papon; Thierry Noël; Martine Florent; Stéphanie Gibot-Leclerc; Dorothée Jean; Christiane Chastin; Jean Villard; Florence Chapeland-Leclerc
Journal:  Antimicrob Agents Chemother       Date:  2006-10-23       Impact factor: 5.191

3.  Cloning and sequencing of a Candida albicans catalase gene and effects of disruption of this gene.

Authors:  D R Wysong; L Christin; A M Sugar; P W Robbins; R D Diamond
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

4.  Aromatic amino-acid biosynthesis in Candida albicans: identification of the ARO4 gene encoding a second DAHP synthase.

Authors:  S A Pereira; G P Livi
Journal:  Curr Genet       Date:  1996-04       Impact factor: 3.886

5.  Stable transformation and regulated expression of an inducible reporter construct in Candida albicans using restriction enzyme-mediated integration.

Authors:  D H Brown; I V Slobodkin; C A Kumamoto
Journal:  Mol Gen Genet       Date:  1996-04-24

6.  Overexpression of a dominant-negative allele of SEC4 inhibits growth and protein secretion in Candida albicans.

Authors:  Y Mao; V F Kalb; B Wong
Journal:  J Bacteriol       Date:  1999-12       Impact factor: 3.490

7.  Selection against the dihydrofolate reductase-thymidylate synthase (DHFR-TS) locus as a probe of genetic alterations in Leishmania major.

Authors:  F J Gueiros-Filho; S M Beverley
Journal:  Mol Cell Biol       Date:  1996-10       Impact factor: 4.272

8.  Induced chromosome rearrangements and morphologic variation in Candida albicans.

Authors:  R C Barton; S Scherer
Journal:  J Bacteriol       Date:  1994-02       Impact factor: 3.490

9.  The Candida albicans PMM1 gene encoding phosphomannomutase complements a Saccharomyces cerevisiae sec 53-6 mutation.

Authors:  D J Smith; M Cooper; M DeTiani; C Losberger; M A Payton
Journal:  Curr Genet       Date:  1992-12       Impact factor: 3.886

10.  Candida albicans mutations in the ergosterol biosynthetic pathway and resistance to several antifungal agents.

Authors:  Dominique Sanglard; Françoise Ischer; Tania Parkinson; Derek Falconer; Jacques Bille
Journal:  Antimicrob Agents Chemother       Date:  2003-08       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.